Education
About Us
Working with TipRanks
Follow Us
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
Technical Sentiment
Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting BridgeBio Oncology Therapeutics is a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 12.14, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 12.12, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
10.74
11.24
11.56
12.06
12.38
12.87
13.19
Fibonacci
11.24
11.55
11.74
12.06
12.37
12.56
12.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
11.96Sell
11.97Sell
MA10
12.28Sell
12.09Sell
MA20
12.17Sell
12.14Sell
MA50
12.20Sell
12.12Sell
MA100
11.99Sell
11.88Sell
MA200
11.26Buy
11.41Buy
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 12.09, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 11.88, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 12.20, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 11.99, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 11.26, creating a Buy signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
46.02
Neutral
STOCH (9,6)
31.73
Neutral
STOCHRSI (14)
31.73
Neutral
MACD (12,26)
-0.04
Buy
ADX (14)
14.93
Buy
Williams %R
-73.95
Buy
CCI (14)
-68.00
Neutral
ATR (14)
0.92
-
Ultimate Oscillator
41.12
Neutral
ROC
-2.91
Sell
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 46.02, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 14.93, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -68.00, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is -2.91, creating a Sell signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Sell.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 46.02, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is -0.04, which suggests BBOT is a Buy.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 11.96, which suggests BBOT is a Sell.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 12.17, which suggests BBOT is a Sell.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 12.20, which suggests BBOT is a Sell.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 11.26, which suggests BBOT is a Buy.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -73.95, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is -68.00, which suggests BBOT is a Neutral.